Clinical Trials Browser

Phase 3 × Immune Checkpoint Inhibitors × Head & Neck × Clear all

NCT05941741 2026-03-18

IC Plus Low-dose Radiation Plus Cadonilimab in LANPC

Phase 3 Recruiting

Nasopharyngeal Carcinoma

NCT07238569 2025-11-20

Phase III Trial of EBV-DNA-Guided Adaptive Immunotherapy for Advanced Nasopharyngeal Carcinoma

Phase 3 Not yet recruiting

Nasopharyngeal Cancinoma (NPC)

NCT04907370 2025-07-16

DIAMOND

Phase 3 Active not recruiting

Nasopharyngeal Carcinoma